Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Leukemia|May 15, 2015
p53-dependent non-coding RNA networks in chronic lymphocytic leukemiaC J Blume, A Hotz-Wagenblatt, J Hüllein, et al.Der Pathologe|March 1, 2021
[COVID-19 and the central and peripheral nervous system]N Ritschel, H Radbruch, C Herden, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparisonI Herth, S Dietrich, A Benner, et al.Leukemia|November 6, 2014
The impact of SF3B1 mutations in CLL on the DNA-damage responseG D Te Raa, I A M Derks, V Navrkalova, et al.Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.Lancet (London, England)|October 5, 2010
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialM Hallek, K Fischer, G Fingerle-Rowson, et al.Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.Nature Genetics|May 31, 2001
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degenerationB Oosthuyse, L Moons, E Storkebaum, et al.Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.Leukemia|November 29, 2016
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemiaE Young, D Noerenberg, L Mansouri, et al.Pageof 4